Based on WHO grading, gliomas can be classified from Grade 1 (least aggressive) to Grade 4 (most aggressive), and based on mutations in the isocitrate dehydrogenase gene, the tumor can be classified as IDH mutant or IDH non-mutant [56]. This evidence concerns the gene IDH1 and central nervous system cancer.